Audio Interview: New Data on Remdesivir in Covid-19.N Engl J Med. 2020 05 28; 382(22):e94.NEJM
Links
MeSH
Adenosine MonophosphateAdultAlanineAntiviral AgentsBetacoronavirusCOVID-19Coronavirus InfectionsDrug Administration ScheduleDrug EvaluationHumansHydroxychloroquineInfusions, IntravenousPandemicsPlacebosPneumonia, ViralRandomized Controlled Trials as TopicSARS-CoV-2Time FactorsTreatment OutcomeViral Load
Pub Type(s)
Editorial
Interview
Language
eng
PubMed ID
32459948
Citation
Rubin, Eric J., et al. "Audio Interview: New Data On Remdesivir in Covid-19." The New England Journal of Medicine, vol. 382, no. 22, 2020, pp. e94.
Rubin EJ, Baden LR, Morrissey S. Audio Interview: New Data on Remdesivir in Covid-19. N Engl J Med. 2020;382(22):e94.
Rubin, E. J., Baden, L. R., & Morrissey, S. (2020). Audio Interview: New Data on Remdesivir in Covid-19. The New England Journal of Medicine, 382(22), e94. https://doi.org/10.1056/NEJMe2019975
Rubin EJ, Baden LR, Morrissey S. Audio Interview: New Data On Remdesivir in Covid-19. N Engl J Med. 2020 05 28;382(22):e94. PubMed PMID: 32459948.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Audio Interview: New Data on Remdesivir in Covid-19.
AU - Rubin,Eric J,
AU - Baden,Lindsey R,
AU - Morrissey,Stephen,
PY - 2020/5/28/entrez
PY - 2020/5/28/pubmed
PY - 2020/6/2/medline
SP - e94
EP - e94
JF - The New England journal of medicine
JO - N Engl J Med
VL - 382
IS - 22
SN - 1533-4406
UR - https://www.unboundmedicine.com/medline/citation/32459948/Audio_Interview:_New_Data_on_Remdesivir_in_Covid_19_
L2 - https://www.nejm.org/doi/10.1056/NEJMe2019975?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed
DB - PRIME
DP - Unbound Medicine
ER -